PTN Palatin Technologies, Inc.

Partial data
10.86USD+14.80%Mkt Cap: 18.18M $P/E: 92.91

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral sma…

Key Statistics

Company
Market Cap18.18M USD
Enterprise Value9.45M USD
Revenue (TTM)12.88M USD
Gross Profit0 USD
Net Income (TTM)-17.31M USD
Revenue/Share6.28 USD
Last Price10.86 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6960775020
Valuation
P/E (Trailing)92.91
P/E (Forward)-4.47
PEG1.62
EV/EBITDA-1.08
EV/Revenue0.73
P/S1.50
P/B1.82
EPS (TTM)0.11
EPS (Forward)-2.43
52W Range
5.61021% of range31.00
52W High31.00 USD
52W Low5.610 USD
Profitability
Gross Margin4.28%
Oper. Margin-40.33%
EBITDA Margin-67.93%
Profit Margin-48.50%
ROE362.30%
ROA-529.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.31M USD
CapEx (TTM)—
FCF Margin-106.12%
FCF Yield-75.19%
Net Debt-9.87M USD
Net Debt/EBITDA1.13
Balance Sheet
Debt/Equity-0.03
Current Ratio5.04
Quick Ratio4.86
Book Value/Sh5.96 USD
Cash/Share5.71 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateAug 12, 2025
Analyst Consensus
Rating—
Target (Mean)53.50 USD
Upside (mean)+392.6%
Target Range47.50 USD – 60.00 USD
47.50+392.6% to mean60.00
# Analysts3
Ownership
Shares Out.1.78M
Float1.49M
Insiders7.86%
Institutions50.16%
Short Interest
Short Ratio8.6d
Short % Float20.41%
Short % Out.19.42%
Shares Short345.48K
Short (prev mo.)296.66K
Technical
SMA 509.697 (+12.0%)
SMA 20015.78 (-31.2%)
Beta-0.04
S&P 52W Chg14.29%
Avg Vol (30d)91.65K
Avg Vol (10d)155.09K
Technical Indicators
RSI (14)50.6
MACD0.5100
MACD Signal0.6583
MACD Hist.-0.1484
BB Upper13.80 USD
BB Middle11.08 USD
BB Lower8.358 USD
BB Width49.11%
ATR (14)1.427 USD
Vol Ratio (20d)0.40x